4.7 Article

Bi2O3/ZnO nanocomposite: Synthesis, characterizations and its application in electrochemical detection of balofloxacin as an anti-biotic drug

期刊

JOURNAL OF PHARMACEUTICAL ANALYSIS
卷 11, 期 1, 页码 57-67

出版社

ELSEVIER
DOI: 10.1016/j.jpha.2020.03.013

关键词

ZnO nanoparticles; Chemically modified electrode; Voltammetry; Drug analysis

资金

  1. University Grants Commission (UGC)

向作者/读者索取更多资源

A chemically modified electrode utilizing Bi2O3/ZnO nanocomposite was constructed for sensitive voltammetric detection of the antibiotic drug balofloxacin. The modified electrode showed excellent electrocatalytic activity towards balofloxacin oxidation with wide linear response range and low detection limit. It offered advantages of simplicity, stability, reproducibility, and selectivity, making it suitable for practical applications in pharmaceutical analysis.
In the present work, a chemically modified electrode has been fabricated utilizing Bi2O3/ZnO nanocomposite. The nanocomposite was synthesized by simple sonochemical method and characterized for its structural and morphological properties by using XRD, FESEM, EDAX, HRTEM and XPS techniques. The results clearly indicated co-existence of Bi2O3 and ZnO in the nanocomposite with chemical interaction between them. Bi2O3/ZnO nanocomposite based glassy carbon electrode (GCE) was utilized for sensitive voltammetric detection of an anti-biotic drug (balofloxacin). The modification amplified the electroactive surface area of the sensor, thus providing more sites for oxidation of analyte. Cyclic and square wave voltammograms revealed that Bi2O3/ZnO modified electrode provides excellent electrocatalytic action towards balofloxacin oxidation. The current exhibited a wide linear response in concentration range of 150-1000 nM and detection limit of 40.5 nM was attained. The modified electrode offered advantages in terms of simplicity of preparation, fair stability (RSD 1.45%), appreciable reproducibility (RSD 2.03%) and selectivity. The proposed sensor was applied for determining balofloxacin in commercial pharmaceutical formulations and blood serum samples with the mean recoveries of 99.09% and 99.5%, respectively. (C) 2020 Xi'an Jiaotong University. Production and hosting by Elsevier B.V.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据